期刊文献+

^(99)Tc^m标记右旋糖苷衍生物的制备及其生物分布 被引量:5

Preparation and Biodistribution Study of ^(99)Tc^m Labelled Dextran Conjugates
下载PDF
导出
摘要 采用Isolink药盒制备了羰基锝[99 Tcm(CO)3(H2O)3]+,用制备的羰基锝标记右旋糖苷衍生物;将标记物由小鼠的后足脚垫皮下注射,分别于给药后1、4h处死(处死前10min注入专利蓝溶液),取前哨淋巴结(Sentinel Lymph Node,SLN)、次级淋巴结(2LN)、注射点、肝、脾、血,分别测量其放射性计数,计算组织或器官的放射性摄取率,研究甘露糖基和右旋糖苷衍生物相对分子质量对小鼠淋巴结摄取及体内分布的影响。结果显示:当分子中不含甘露糖基时,SLN的摄取率很低,在注射点的摄取也相对较少,并且体内清除较快;而当分子中含有甘露糖基时,SLN的摄取率大幅提高,但在注射点的滞留也显著提高。以上结果表明,分子中的甘露糖基对淋巴结巨噬细胞表面受体具有亲和作用。另外,右旋糖苷衍生物相对分子质量的不同,也会造成不同的生物分布,相对分子质量较大的标记化合物,SLN提取更高,差异显著(P<0.005);此外,标记物的注射剂量和注射体积也会对SLN的摄取产生较大影响。99 Tcm标记的甘露糖基化右旋糖苷衍生物具有优良的淋巴结摄取及体内分布性质,作为潜在的SLN显像剂,值得进一步研究。 99Tcm Mannosylated dextran conjugates were prepared through [99 Tcm, (CO)3]+ precursor synthesized by carbonyl Isolink kit. The labelled conjugates were injected sub- dermally into the rear loots of the mice, and the patent blue solution was injected at the same site 10 rain before sacrifice. The mice were killed at 1 h and 4 h postinjection, and the samples of different tissues including SLN, 2LN, injection site, liver, spleen, blood were dissected and counted. The uptake in terms was calculated. The results of biodistribution demonstrated that the SLN uptakes of radiopharmaceutical (without mannose in the mole- cules) were rather low and in vivo excretion of these conjugates were comparatively faster, and the uptake of injection site was also low; on the other hand, the SLN uptakes of radio-pharmaceutical (with mannose in their molecules) were much higher than those of their cor- responding dextran conjugates without mannose, but the retention in the injection site of these conjugates increased too. The results indicated that the affinity of mannosyl-dextran conjugates to the receptors on the surface of macrophages in the lymph node. In addition, the different relative molecular mass of dextran conjugates also cause different biodistribu- tion results, the major one had higher SLN uptake, the difference was significant (P〈0. 005) , moreover, the injected dosage of the labelled conjugates also had an affect on SLN uptakes. The [99Tcm(CO)3]+ labelled mannosylated dextran conjugates showed prom- ising properties as SLN imaging agent and worth further investigation.
出处 《同位素》 CAS 2012年第3期149-154,共6页 Journal of Isotopes
基金 IAEA CRP项目(14513)
关键词 99Tcm 前哨淋巴结(SLN) 右旋糖苷衍生物 甘露糖基化 羰基锝 99Tcm sentinel lymph node (SLN) dextran conjugates mannosylated [99Tcm(CO)3]+
  • 相关文献

参考文献9

  • 1Mariani G, Moresco L, Viale G, et al. Radioguid- ed sentinel lymph node biopsy in breast cancer sue- gery[J]. J NuclMed, 2001, 42= 1 198-1 215.
  • 2Easson AM, Rotstein IrE, McCready DR. Lymph node assessment in melanoma[J]. J Surg Oncol, 2009, 99: 176-185.
  • 3李艳,李囡,翟士桢,王雪鹃,杨志.特异性前哨淋巴结显像剂^(99)Tc^m-rituximab药盒的制备及生物评价[J].同位素,2011,24(B12):85-89. 被引量:7
  • 4Antonia W, Carl KH, Jeanette M, et al. Molecu- lar imaging of the sentinel lymph node via lympho- seek[J]. Current Clinical Oncology, 2009, 4: 123-133.
  • 5Hoh CK, Wallace AM, Vera DR. Preclinical stu-dies of [99Tcm]DTPA mannosyl-dextran[J]. Nuel Med Biol, 2003, 30(5): 457-464.
  • 6Ellner SJ, Hoh CK, Vera DR, et al. Dose-de pendent biodistribution of [99 Tcm ]DTPA- manno syl-dextran for breast cancer sentinel lymph node mapping[J]. Nucl Med Bio, 2003, 30 (8): 805-810.
  • 7Kyoko T, Tomoya U, Emi K, et al. 99Tcr'-la beled mannosyl-neoglycoalbumin for sentinel lymph node identification [J]. Nuel Med Biol, 2004, 31(7): 893 900.
  • 8Pirmettis I, Arano Y, Tsotakos T, et aI. New 99 Tcm (CO) (3) Mannosylated dextran bearing S derivatized cysteine chelator for sentinel lymph node detection[J]. Mol Pharm, 2012, 9(6): 1 681 1 692.
  • 9李洪玉,梁积新,罗洪义,陈宝军,杨春慧,郑德强.^(99)Tc^m-硫化铼胶体用于前哨淋巴结检测的生物实验——注射剂量与明胶浓度的影响[J].同位素,2011,24(2):72-76. 被引量:5

二级参考文献18

  • 1王雪鹃,王荣福,杨志,林保和,徐冰,张岩,张梅颖.前哨淋巴结示踪剂^(99)Tc^m-IT-Rituximab的制备及初步动物实验研究[J].中国医学影像技术,2006,22(1):139-143. 被引量:5
  • 2王雪鹃,杨志,林保和,徐冰,张岩,张梅颖.前哨淋巴结显像剂^(99)Tc^m-IT-Rituximab的制备及其定位性能[J].中华核医学杂志,2006,26(4):226-230. 被引量:13
  • 3Mariani G, Moresco L, Viale G, et al. Radiogui- ded sentinel lymph node biopsy in breast cancer surgery[J]. J Nucl Med, 2001, 42:1 198-1 215.
  • 4Easson AM, Rotstein LE, McCready DR. Lymph node assessment in melanoma[J]. J Surg Oncol, 2009, 99: 176-185.
  • 5Takagi K, UMehara T, Kaneko E, et al. ^99mTc- labeled mannosyl-neoglycoalbumin for sentinel lymph node identification [J]. Nucl Med Biol,2004, 31: 893-900.
  • 6Vera DR, Wallace AM, Hoh CK, et al. A Syn- thetic Macromolecule for sentinel node detection: ^99Tc^m -DTPA-mannosyl-dextran[J]. J Nucl Med, 2001, 42:951-959.
  • 7Wallace AM, Hoh CK, Darrah DD, et al. Senti- nel lymph node mapping of breast cancer via intra- dermal administration of Lymphoseek [J]. Nucl Med Biol, 2007, 34: 849-853.
  • 8Mariani G, Erba P, Villa G, et ah Lymphoscinti- graphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective[J]. J Surg Oncol, 2004, 85: 112-22.
  • 9Wilhelm AJ, Mijnhout GS, Franssen EJ. Radio- pharmaceuticals in sentinel lymph-node detection- an overview[J]. Eur J Nucl Med, 1999, 26: S36-S42.
  • 10NANOCIS: Kit for the preparation of technetium [^99 Tc^m] colloidal rhenium sulphide injection (Nanocolloid) Summary of Product Characteristics fEB/OLd. ( 2007-01 ) [2011-04-11] http://www. radmed. com. tr/usr_img/urunler/nancolloid. pdf.

共引文献9

同被引文献50

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部